Hashimoto's autoimmune thyroiditis and vitamin D deficiency. Current aspects

Hellenic Journal of Nuclear Medicine

Volumn 17, Issue 1, 2014, Pages 37-40

  Mazokopakis, Elias E ^a   Kotsiris, Dimitrios A ^a  

^a Naval Hospital of Crete   (Greece)

Author keywords

Autoimmunity; Hashimoto's thyroiditis; Vitamin D

Indexed keywords

GAMMA INTERFERON; HLA DR ANTIGEN; VITAMIN D; VITAMIN D RECEPTOR;

AUTOIMMUNITY; COST EFFECTIVENESS ANALYSIS; GENETIC POLYMORPHISM; HASHIMOTO DISEASE; HUMAN; LYMPHOCYTE; MAJOR HISTOCOMPATIBILITY COMPLEX; OPTIMAL DRUG DOSE; PATHOGENESIS; REVIEW; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 84900436304     PISSN: 17905427     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Mazokopakis EE, Chatzipavlidou V. Hashimoto's thyroiditis and the role of selenium. Current concepts. Hell J Nucl Med 2007; 10: 6-8.
2. Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: Clinical and diagnostic criteria. Autoimmun Rev 2014 [Epub ahead of print].
3. Mazokopakis EE, Papadakis JA, Papadomanolaki MG et al. Effects of 12 months treatment with L-selenomethionine on serum anti-TPO Levels in Patients with Hashimoto's thyroiditis. Thyroid 2007; 17: 609-12.
4. Mazokopakis EE, Tzortzinis AA, Dalieraki-Ott EI et al. Coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma. A retrospective study. Hormones (Athens) 2010; 9: 312-7.
5. Dayan, CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med 1996; 335: 99-107.
6. Kivity S, Agmon-Levin N, Zisappl M et al. Vitamin D and autoimmune thyroid diseases. Cell Mol Immunol 2011; 8: 243-7.
7. Chistiakov DA. Immunogenetics of Hashimoto's thyroiditis. J Autoimmune Dis 2005; 2: 1.
8. Stefanić M, Papić S, Suver M et al. Association of vitamin D receptorgene 3′-variants with Hashimoto's thyroiditis in the Croatian population. Int J Immunogenet 2008; 35: 125-31.
9. Lacka K, Maciejewski A. Vitamin D in the etiopathogenesis of autoimmune thyroiditis. Pol Merkur Lekarski 2013; 34: 281-5.
10. Kotsa K, Watson PF, Weetman AP. A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune hypothy roidism. Clin Endocrinol (Oxf) 1997; 46: 551-4.
11. Yarman S, Mudun A, Alagol F et al. Scintigraphic varieties in Hashimoto's thyroiditis and comparison with ultrasonography. Nucl Med Commun 1997; 18: 951-6.
12. Kotani T, Umeki K, Matsunaga S et al. Detection of autoantibodies to thyroid peroxidase in autoimmune thyroid diseases by micro- ELISA and immunoblotting. J Clin Endocrinol Metab 1986; 62: 928-33.
13. Zabek J. Assessment methods of autoantibodies in autoimmune diseases. Przegl Epidemiol 2002; 56(Suppl 4): 59-66.
14. Tamer G, Arik S, Tamer I, Coksert D. Relative vitamin D insufficiency in Hashimoto's thyroiditis. Thyroid 2011; 21: 891-6.
15. Rosen CJ. Clinical practice. Vitamin D insufficiency. N Engl J Med 2011; 364: 248-54.
16. Shoback D, Sellmeyer D, Bikle DD. Metabolic bone disease. In: Gardner DG, Shoback D (Eds). Greenspan's basic and clinical endocrinology. New York, NY: Lange Medical Books/ McGraw-Hill, 2007: 288-97.
17. Brannon PM, Yetley EA, Bailey RL, Picciano MF. Overview of the conference "Vitamin D and Health in the 21st Century: an Update". Am J Clin Nutr 2008; 88: 483S-90S.
18. Holick MF, Binkley NC, Bischoff-Ferrari HA et al Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline [published correction appears in J Clin Endocrinol Metab 2011; 96: 3908]. J Clin Endocrinol Metab 2011; 96: 1911-30.
19. Agmon-Levin N, Theodor E, Segal RM, Shoenfeld Y. Vitamin D in systemic and organ-specific autoimmune diseases. Clin Rev Allergy Immunol 2013; 45: 256-66.
20. Lamprecht SA, Lipkin M. Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms. Nat Rev Cancer 2003; 3: 601-14.
21. Verstuyf A, Carmeliet G, Bouillon R, Mathieu C. Vitamin D: a pleiotropic hormone. Kidney Int 2010; 78: 140-5.
22. Zhang R, Naughton DP. Vitamin D in health and disease: current perspectives. Nutr J 2010; 9: 65.
23. Karefylakis C, Näslund I, Edholm D et al. Vitamin D status 10 years after primary gastric bypass: gravely high prevalence of hypovitaminosis D and raised PTH levels. Obes Surg 2014; 24(3): 343-8.
24. Souberbielle JC, Body JJ, Lappe JM et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun Rev 2010; 9: 709-15.
25. Ramagopalan SV, Goldacre R, Disanto G et al. Hospital admissions for vitamin D related conditions and subsequent immune-mediated disease: record-linkage studies. BMC Med 2013; 11:171.
26. Kopes-Kerr C. Should family physicians routinely screen for vitamin D deficiency? No: screening is unnecessary, and routine supplementation makes more sense. Am Fam Physician 2013; 87(8): od2.
27. Bozkurt NC, Karbek B, Ucan B et al. The association between severity of vitamin D deficiency and Hashimoto's thyroiditis. Endocr Pract 2013; 19: 479-84.
28. Goswami R, Marwaha RK, Gupta N et al. Prevalence of vitamin D deficiency and its relationship with thyroid autoimmunity in Asian Indians: a community-based survey. Br J Nutr 2009; 102: 382-6.
29. Effraimidis G, Badenhoop K, Tijssen JG, Wiersinga WM. Vitamin D deficiency is not associated with early stages of thyroid autoimmunity. Eur J Endocrinol 2012; 167: 43-8.
30. Lin WY, Wan L, Tsai CH et al. Vitamin D receptor gene polymorphisms are associated with risk of Hashimoto's thyroiditis in Chinese patients in Taiwan. J Clin Lab Anal 2006; 20: 109-12.
31. Pani MA, Regulla K, Segni M et al. A polymorphism within the vitamin D-binding protein gene is associated with Graves' disease but not with Hashimoto's thyroiditis. J Clin Endocrinol Metab 2002; 87: 2564-7.
32. Pani MA, Regulla K, Segni M et al. Vitamin D 1alpha-hydroxylase (CYP1alpha) polymorphism in Graves' disease, Hashimoto's thyroiditis and type 1 diabetes mellitus. Eur J Endocrinol 2002; 146: 777-81.
33. Stefanic M, Karner I, Glavas-Obrovac L et al. Association of vitamin D receptor gene polymorphism with susceptibility to Graves' disease in Eastern Croatian population: case-control study. Croat Med J 2005; 46: 639-46.
34. Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: Vitamins A and D take centre stage. Nat Rev Immunol 2008; 8: 685-98.
35. Hewison M. An update on vitamin D and human immunity. Clin Endocrinol (Oxf) 2012; 76: 315-25.
36. Adams JS, Hewison M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 2008; 4: 80-90.
37. Barragán-Garfias JA, Zárate A. Relation between autoimmune thyroid diseases and connective tissue diseases. Rev Med Inst Mex Se guro Soc 2013; 51: e1-5.
38. Dilas LT, Icin T, Paro JN, Bajkin I. Autoimmune thyroid disease and other non-endocrine autoimmune diseases. Med Pregl 2011; 64: 183-7.
39. Silverberg JI, Silverberg AI, Malka E, Silverberg NB. A pilot study assessing the role of 25 hydroxy vitamin D levels in patients with vitiligo vulgaris. J Am Acad Dermatol 2010; 62: 937-41.
40. Chen W, Lin H, Wang M. Immune intervention effects on the induction of experimental autoimmune thyroiditis. J Huazhong Univ Sci Technolog Med Sci 2002; 22: 343-5, 354.
41. Fournier C, Gepner P, Sadouk M, Charreire J. In vivo beneficial effects of cyclosporin A and 1,25-dihydroxyvitamin D3 on the induction of experimental autoimmune thyroiditis. Clin Immunol Immunopathol 1990; 54: 53-63.
42. Robien K, Oppeneer SJ, Kelly JA, Hamilton-Reeves JM. Drug-vitamin D interactions: a systematic review of the literature. Nutr Clin Pract 2013; 28: 194-208.